Sagent Pharms Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for SAGENT PHARMS INC, and what generic and branded alternatives to SAGENT PHARMS INC drugs are available?
SAGENT PHARMS INC has fifty-six approved drugs.
Drugs and US Patents for Sagent Pharms Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sagent Pharms Inc | CISATRACURIUM BESYLATE | cisatracurium besylate | INJECTABLE;INJECTION | 201851-001 | Nov 6, 2020 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 209077-002 | Jul 20, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Sagent Pharms Inc | METHOTREXATE SODIUM PRESERVATIVE FREE | methotrexate sodium | INJECTABLE;INJECTION | 203407-002 | Aug 9, 2018 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.